Is Wegovy Safe During Pregnancy — and What Should You Do If You're Expecting?

The decision is already made by the licence, but the detail still matters

One misconception that comes up surprisingly often is that the pregnancy restriction on Wegovy is a precaution invented by cautious pharmacies, not a genuine clinical position. It is not. The MHRA-approved licence and the summary of product characteristics for Wegovy state explicitly that it must not be used during pregnancy. The NHS medicines page for semaglutide echoes this directly, advising patients to stop treatment and seek medical advice immediately if they become pregnant.

The reasoning matters. In animal studies, semaglutide caused developmental problems at doses that sit within the human therapeutic range. That does not confirm the same risk in people, but it means there is enough concern to make clinical study in pregnant women inappropriate, which is why the human data are thin. If you want to understand how researchers and regulators have assessed those findings, our page on semaglutide pregnancy risk sets out the evidence in detail. Absence of evidence is not the same as evidence of safety, and regulators have been explicit about which side of that line semaglutide sits on.

So this is not really a decision to weigh up; it is a clear instruction. What does require thought is the plan around it: when to stop, how long to wait, and what happens to weight management in the meantime.

Stopping Wegovy: timing, washout, and what to expect

Semaglutide has a long half-life. After your last weekly injection it typically takes around five weeks for the medicine to clear your body fully. UK guidance, reflected on the NHS England weight-management injections page, advises using effective contraception while on treatment and for a period after stopping, precisely because of this washout window.

If you are planning a pregnancy, the conversation to have with your prescriber or GP is how far ahead to stop. There is no single universal answer; it depends on your circumstances, your dose, and your overall health picture. What is consistent is that stopping the week you get a positive test is later than ideal, even if it is better than continuing.

Appetite often returns when semaglutide clears the system, and some weight regain is common. That is not a reason to delay stopping, it is a reason to plan ahead. A GP or specialist can help you think about diet, activity and monitoring in the months before conception so that you are in the best position going in.

You can read more about how Wegovy works and what to expect when stopping on our Wegovy overview page.

Breastfeeding and trying to conceive, the same caution applies

The guidance does not apply only to confirmed pregnancy. Wegovy is also not recommended while breastfeeding, because it is unknown whether semaglutide passes into breast milk and what effect that could have on a nursing infant. The precautionary answer is to avoid it until breastfeeding has finished.

For people actively trying to conceive, the advice is equally cautious. Given the washout time involved and the animal study findings, most prescribers would advise stopping Wegovy in advance of attempting pregnancy, not just after a positive test, and our page looking at whether Wegovy is safe for pregnancy explains the clinical reasoning behind that position in full. The NHS semaglutide guidance is worth reading on this point, as is speaking directly to your GP about your individual plan.

It is also worth knowing that obesity itself carries risks in pregnancy, including gestational diabetes, hypertension, and complications at delivery. The goal of managing weight before pregnancy is not abandoned because Wegovy is off the table, it is pursued through other means. Your GP or a specialist can discuss what is available and appropriate for you specifically.

For a fuller picture of the side-effect and safety profile of semaglutide outside pregnancy, our Wegovy side effects page covers the common and uncommon effects reported in clinical trials and post-marketing monitoring.

Who to talk to, and where weight management fits after pregnancy

If you are pregnant and have been taking Wegovy: stop the medicine and contact your GP or midwife today. They will note it in your records, advise on any monitoring and discuss your weight management plan for the pregnancy. Our page covering Wegovy side effects in pregnancy is a useful reference for understanding what to tell your midwife and what to look out for. There is no clinical benefit to continuing, and the potential for harm is real enough that waiting is not sensible.

If you are planning a pregnancy in the next six to twelve months: raise it at your next prescriber review. A GPhC-registered prescriber can help you map out a stopping plan and discuss what lifestyle support looks like in the interim. Our frequently asked questions cover some of the common queries around pausing and restarting treatment.

After pregnancy and breastfeeding have ended, weight management options open back up. Our page on whether semaglutide is safe in pregnancy is also worth revisiting at that stage, as it explains why the restrictions exist and what changes once you are no longer pregnant or breastfeeding. Semaglutide for weight loss remains a private prescription medicine in the UK and requires a fresh clinical assessment each time. If you want to explore treatment once your circumstances have changed, our prescribers are available through a free consultation, assessment is carried out personally by a GPhC-registered Independent Prescriber, not by software. You can learn more about what the process involves on our treatment page.